Clinical Trial Update: Testing the Effectiveness of Cognitive Training Among Depressed Patients Receiving Esketamine Treatment [NA]

View source ↗

Summary

A clinical trial evaluating cognitive training for patients with major depressive disorder receiving esketamine has been suspended, per the sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SPRAVATO (ESKETAMINE HYDROCHLORIDE)

Snippet

Sponsor: University of Pittsburgh | Conditions: Depression | NA | Status: SUSPENDED